Information for Shareholders and Investors
Last news and press notes.
26 jan, 2016
Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb)
14 dec, 2015
Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company Download (22.3 Kb)
06 nov, 2015
The intermediate results from the Grifols AMBAR study support its continuation Download (31.1 Kb)